Resistens mod nelfinavir, defineret som tilstedeværelse af D30N eller L90M mutation i protease, blev observeret hos 41/ 96 (43%) forsøgspersoner.
Resistance to nelfinavir, defined as the presence of the D30N or L90M mutation in protease, was observed in 41/ 96 (43%) subjects.